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Background: Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of adult T-cell leukemia and
tropical spastic paraparesis. HTLV-1 encodes transactivator protein Tax that interacts with various cellular factors to
modulate transcription and other biological functions. Additional cellular mediators of Tax-mediated transcriptional
activation of HTLV-1 long terminal repeats (LTR) remain to be identified and characterized.
Results: In this study, we investigated the regulatory role of group I p21-activated kinases (Paks) in Tax-induced LTR
activation. Both wild-type and kinase-dead mutants of Pak3 were capable of potentiating the activity of Tax to
activate LTR transcription. The effect of Paks on the LTR was attributed to the N-terminal regulatory domain and
required the action of CREB, CREB-regulating transcriptional coactivators (CRTCs) and p300/CREB-binding protein.
Paks physically associated with Tax and CRTCs. Paks were recruited to the LTR in the presence of Tax. siRNAs
against either Pak1 or Pak3 prevented the interaction of Tax with CRTC1 and the recruitment of Tax to the LTR.
These siRNAs also inhibited LTR-dependent transcription in HTLV-1-transformed MT4 cells and in cells transfected
with an infectious clone of HTLV-1.
Conclusion: Group I Paks augment Tax-mediated transcriptional activation of HTLV-1 LTR in a kinase-independent manner.
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Human T-cell leukemia virus type 1 (HTLV-1) infects
more than 20 million people worldwide and causes adult
T-cell leukemia (ATL) or tropical spastic paraparesis
(TSP) in a small subset of infected individuals. While ATL
is a highly lethal malignancy of T lymphocytes, TSP is a
disabling neuroinflammatory disorder of the central ner-
vous system [1]. Although the development of ATL and
TSP is rare and slow, high proviral load is the major risk
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reproduction in any medium, provided the orUnderstanding the mechanism by which HTLV-1 drives
proviral expression might provide new strategies for pre-
vention and control of HTLV-1-associated diseases.
The master regulator of HTLV-1 proviral expression is
viral transactivator Tax which potently activates transcrip-
tion from the long terminal repeats (LTR). For this activa-
tion, Tax forms a dimer to complex with dimeric CREB and
the three imperfectly conserved Tax-responsive elements
(TREs) in the LTR [3-5]. Tax also engages transcriptional
coactivators such as p300/CREB-binding protein (CBP) and
CREB-regulating transcriptional coactivators (CRTCs), also
known as transducers of regulated CREB activity (TORCs)
[5-10]. In addition, phosphorylation of Tax, CREB and
CRTCs has also been implicated in LTR activation [10-14].
Because the activation of the LTR by Tax is a tightly regu-
lated process accomplished through multiple mechanismstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cellular proteins might also be involved in its execution and
regulation. Particularly, it will be of great interest to see
whether any Tax-binding protein kinases would play a role
in this process.
p21-activated kinase 3 (Pak3) is one of the 32 Tax-
binding proteins identified in a mass spectrometric ana-
lysis of proteins precipitated from HTLV-1-transformed
C8166 cells using an anti-Tax antibody [18]. However,
the roles of Pak3 in Tax-induced LTR activation have
not yet been characterized. Paks are a family of serine-
threonine kinases that regulate gene transcription, cell
cycle progression, cytoskeletal organization and cell mi-
gration in response to small GTPases Cdc42 and Rac1
[19]. Pak signaling is commonly activated in cancer cells
[20-22]. Paks are also implicated in the replication and
spread of viruses such as human immunodeficiency virus
type 1 (HIV-1) [23]. Currently there are six members in
the Pak family that can be divided into group I (Pak1,
Pak2 and Pak3) and group II (Pak4, Pak5 and Pak6) based
on structural and biochemical properties. They have
highly conserved Cdc42/Rac-interactive binding (CRIB)
domain and kinase domain, but differ in tissue distribution
and the N-terminal regulatory domain. Particularly, CRIB
and kinase domains in Pak1, Pak2 and Pak3 share more
than 95% identity [19]. It is noteworthy that Paks can ful-
fill some of their functions, such as the adaptor role in sig-
nal transduction, the inhibition of cell cycle progression as
well as the induction of lamellipodia and membrane ruf-
fling, in a kinase-independent manner [24-27].
In this study, we investigated the regulatory roles of
group I Paks in Tax-induced activation of HTLV-1 LTR in
transfected and infected cells. We found that all three Paks
of group I can facilitate Tax-induced LTR activation. This
activity of Paks was kinase-independent and was mediated
through the N-terminal regulatory domain. Tax interacted
with Paks and facilitated their recruitment to the viral pro-
moter. Our work reveals new cellular mediators of HTLV-
1 transcription and a new kinase-independent function of
group I Paks in transcriptional regulation.Results
Augmentation of Tax-induced activation of HTLV-1 LTR
by group I Paks
Pak3 is known to interact with Tax in HTLV-1-transformed
cells [18]. Within group I Paks, Pak1 and Pak2 are strikingly
homologous to Pak3, sharing 80% and 69% identical amino
acid residues [19,20]. While all three Paks in group I are ac-
tivated by Cdc42/Rac to mediate similar biological effects,
they are differentially expressed in different tissues and
might have non-redundant functions by targeting different
substrates. Particularly, Pak1 is abundantly expressed in
brain, muscle and spleen. Pak2 is ubiquitous and Pak3 areprimarily found in the brain [19]. Consistent with the previ-
ous finding on Pak3-Tax interaction in C8166 cells [18], we
detected Pak1, Pak2 and Pak3 mRNA and protein in Jurkat
cells and several lines of HTLV-1-transformed T cells, al-
though the levels of Pak2 were relatively low (data not
shown). With this in mind, we set out to explore whether
Pak1, Pak2 and Pak3 might affect Tax-induced activation of
HTLV-1 LTR.
We expressed Pak1, Pak2 and Pak3 in HeLa cells and
assessed the influence on Tax-activated HTLV-1 LTR ex-
pression (Figure 1A). Although Pak1 did not affect basal
activation of the LTR in the absence of Tax (Figure 1A,
bar 2 compared to bar 1), a dose-dependent augmentation
of Tax activity by Pak1 was observed (Figure 1A, bars 4–6
compared to bar 3). Likewise, Pak2 and Pak3 were also
able to potentiate LTR activation by Tax (Figure 1A, bars
9–11 compared to bar 8, and bars 17–19 compared to bar
16). In contrast, neither Pak5 nor MEKK1 was capable of
augmenting Tax-induced LTR activation (data not shown),
suggesting that the effect is specific to group I Paks. This
augmentation was more pronounced when Tax was limit-
ing. For instance, Tax-induced LTR activation was in-
creased 5–9 fold in the presence of Pak3 when Tax
expression is low (Figure 1B, bars 8–10 compared to bars
2–4), whereas the enhancing effect of Pak3 was only 2–4
fold when Tax was abundant (Figure 1B, bars 11–12 com-
pared to bars 5–6). Furthermore, Pak3 augmented Tax-
induced activation of luciferase reporter expression driven
by the 21-bp TREs alone (Figure 1C, bars 6–8 compared
to bar 5). In support of this, the augmentation by Pak3
was not seen when the three TREs in the LTR were
disrupted (data not shown). Thus, the TREs are both re-
quired and sufficient for the enhancing effect of Pak3 on
Tax-induced activation of HTLV-1 LTR.
We next repeated the experiments in Jurkat cells and
obtained similar results indicating the ability of Pak1 and
Pak3 to further augment LTR activation by Tax (Figure 1D,
bars 4–6 compared to bar 3, and bars 10–13 compared to
bar 9). In addition, when we depleted endogenous Pak1 or
Pak3 in Jurkat cells with a pre-validated siRNA, the activa-
tion of the LTR by Tax was compromised (Additional file 1:
Figure S1A, bars 5 and 6 compared to bar 4). Consistent
with this, Tax-mediated LTR activation was attenuated in
HTLV-1-transformed MT2 and MT4 cells in which Pak1
or Pak3 was depleted by siRNA (Figure 1E, bars 8–10 com-
pared to bar 5; Additional file 1: Figure S1B, bar 4 com-
pared to bar 3). As a positive control, we also verified the
suppression of LTR activation in Tax-depleted MT2 cells
transfected with siTax-A or siTax-B (Figure 1E, bars 6 and
7 compared to bar 5). Since antibodies that can reprodu-
cibly detect endogenous Pak1 and Pak3 proteins in MT2
cells were not available, the silencing effect of siRNAs used
was verified by RT-PCR analysis of Pak1 and Pak3 tran-
scripts. Representative examples of RT-PCR results were
Figure 1 Augmentation of Tax-induced activation of HTLV-1 LTR by group I Paks. (A and B) Augmentation of LTR activation in HeLa cells.
Cells were transfected with the indicated reporter and expression plasmids. A fixed amount of Tax expression plasmid plus escalating amounts of
expression plasmids for Pak1/2/3 (A) or a fix amount of Pak3 expression plasmid plus escalating amounts of Tax plasmid (B) were used. Numbers
at the top of the error bars indicate fold activation. (C) Augmentation of TRE activation in HeLa cells. The reporter plasmid pTRE-Luc contains
three copies of TRE only. (D) Augmentation of LTR activation in Jurkat cells. (E) RNAi depletion of Pak1 or Pak3 dampened LTR activity in HTLV-1
-transformed T cells. MT2 cells were transfected with pre-validated siRNA (100 nM) against Pak1 (siPak1A/B) or Pak3 (siPak3A). Cells were
transfected with pLTR-Luc 30 h after siRNA transfection. Proliferation of MT2 cells were unaffected by siPak as measured by MTT assay.
*: the difference between groups 6 and 5 is statistically significant (p = 0.0020 by Student's t test). #: p = 0.0017. @: p = 0.0018. (F) Paks have no
influence on Tax-induced activation of NFκB in HeLa cells. Dual luciferase assays were performed. Relative luciferase activity (RLA) was calculated
as a ratio of firefly luciferase activity recovered from pLTR-Luc or pHIAP-Luc versus that of Renilla luciferase recovered from co-transfected
pSV-RLuc. Results represent three independent experiments and standard deviations (SD) are indicated by error bars.
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ent siRNAs targeting Pak1 (siPak1A and siPak1B) were
found to have a substantial suppressive effect on Pak1
mRNA expression in HeLa and MT4 cells (Additional
file 2: Figure S2A, lanes 2 and 3 compared to lane 1;
Additional file 2: Figure S2B, lanes 2 and 3 compared tolane 1). They also suppressed Pak3 mRNA expression to a
lesser extent, but did not influence the expression of
β-globin transcript (Additional file 2: Figure S2A, lanes 5
and 6 compared to lane 4; Additional file 2: Figure S2B,
lane 5 compared to lane 4). Likewise, diminution of
the steady-state levels of Pak3 mRNA was most
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siPak3B (Additional file 2: Figure S2). The cross sup-
pression of Pak1 and Pak3 by siPak3 and siPak1 respect-
ively was due to the high homology between Pak1 and
Pak3. Because the expression levels of Pak2 was low in
MT2 and MT4 cells, RNAi depletion experiments were
not performed for Pak2. Nevertheless, our results dem-
onstrated that compromising group I Paks attenuated
Tax-induced activation of HTLV-1 LTR.
In addition to HTLV-1 LTR, Tax can also activate NFκB-
dependent transcription [28]. For example, Tax activates
cellular HIAP promoter through NFκB [29]. Since Pak1
was also implicated in the activation of NFκB [30], we
asked whether Pak1 or Pak3 might influence Tax-induced
activation of NFκB. When we co-expressed Tax with Pak1
or Pak3, the activation of HIAP promoter by Tax was not
further enhanced (Figure 1F, bars 3–5 compared bar 2, and
bars 8–10 compared to bar 7). Additionally, when Pak1 or
Pak3 was depleted from HeLa cells, Tax-induced activation
of HIAP promoter was unaffected (data not shown).
Hence, Pak1 and Pak3 had no influence on Tax-induced
activation of NFκB. Collectively, our gain-of-function and
loss-of-function experiments consistently supported the
notion that group I Paks facilitate Tax-induced LTR activa-
tion specifically.
Pak3 augments Tax-induced activation of HTLV-1 LTR in a
kinase-independent manner
Augmentation of Tax-activated LTR activity by group I
Paks raised the possibility for suppression of HTLV-1 tran-
scription with small-molecule inhibitors of these kinases.
As the first step to test this idea, we sought to determine
the requirement of the kinase activity of Paks for the stimu-
latory effect on HTLV-1 LTR. Since Pak1, Pak2 and Pak3
are strikingly homologous, we focused our analysis on Pak3
only. We constructed various mutants of Pak3, some of
which have been found in patients with X-linked mental re-
tardation caused by a defect in Pak3 [31]. K297L, A365E
and R419X mutants are kinase-defective, whereas T421E is
a dominant active mutant. R67C is a mutant defective of
Cdc42-binding [32]. All mutants were expressed to com-
parable levels (Figure 2A). Several slow-migrating bands
were noted in the samples of Pak3 wild-type (WT) as well
as R67C and T421E mutants (Figure 2A, lanes 2, 4 and 8),
suggesting that they might be auto-phosphorylated. These
slow-migrating bands disappeared when the samples were
treated with calf intestinal phosphatase (Figure 2A, lanes 3,
5 and 9). For the kinase-dead K297L, A365E and R419X
mutants, auto-phosphorylation of Pak3 was not observed
(Figure 2A, lanes 6, 10 and 12). To our surprise, all mutants
of Pak3 still augmented Tax-induced LTR activation equally
well and in a dose-dependent manner (Figure 2B). Hence,
kinase or Cdc42-binding activity of Pak3 was not essential
for augmentation of Tax activity on the LTR.We went on to map the Tax-augmenting domain of
Pak3 using a series of truncated mutants (Figure 3A).
These mutants were expressed to comparable levels in
HeLa cells (Figure 3B) and interrogated for the ability to
potentiate Tax-induced activation of the LTR (Figure 3C).
All mutants except M4, which contains the CRIB domain
alone, were capable of augmenting LTR activation by Tax.
These results indicated that the N-terminal regulatory do-
main (1–68 amino acids) was sufficient for augmentation
of Tax-induced LTR activation. This is generally consistent
with our findings obtained from the analysis of Pak3 point
mutants (Figure 2).
To shed light on the functional domain of Tax that in-
teracts with Pak3, we also examined the effect of Pak3 on
various point mutants of Tax. Pak3 was found to augment
all Tax mutants that are able to activate HTLV-1 LTR
[33,34], including S258A, S150A, and C23S (Additional
file 3: Figure S3). Thus, as in the case of many other Tax-
binding proteins [35], we were unable to define a discrete
domain of Tax that interacts with Pak3. Plausibly, the
interaction is conformation-dependent and requires the
full protein of Tax.
CREB, CRTCs and p300/CBP are required for Tax-
augmenting effect of Pak3
Tax-induced activation of HTLV-1 LTR is mediated
through CREB transcription factor as well as CRTC and
p300/CBP transcriptional coactivators [5,8]. Although Pak3
can augment Tax activity on the LTR, it is unclear whether
the action of Pak3 would bypass any of these mediators. To
address this issue, we employed dominant inactive proteins
A-CREB and CRTC1M1 as well as an adenoviral inhibitor
of p300/CBP known as E1A-12S. A-CREB and CRTC1M1
are well-characterized dominant inhibitory proteins that
specifically impeded the function of CREB and CRTC1, re-
spectively [4,36,37]. Adenoviral E1A-12S is capable of po-
tently inhibiting the activity of p300, CBP and related
transcriptional coactivators [38]. Expression of A-CREB,
CRTC1M1 and E1A-12S even at a relatively low level is
known to exert a dominant inhibitory effect on their spe-
cific targets [36-38]. Their expression in HeLa cells was
verified by Western blotting (Figure 4 insets). Expression of
A-CREB not only abrogated Tax-induced activation of the
LTR, but also erased the Tax-augmenting effect of Pak3
(Figure 4A, bars 6–8 compared to bar 5, and bars 14–16
compared to bar 13). When similar sets of experiments
were repeated with CRTC1M1, the activity of Tax on the
LTR was also diminished both in the absence and in the
presence of Pak3 (Figure 4B, bars 6–8 compared to bar 5,
and bars 14–16 compared to bar 13), although the inhib-
ition was incomplete plausibly due to redundant function
of CRTC2 and CRTC3 [8]. Finally, inhibition of p300/CBP
by E1A-12S effectively blunted the activity of Tax or Tax +
Pak3 on the LTR (Figure 4C, bars 6–8 compared to bar 5,
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compatible with the notion that CREB, CRTCs and p300/
CBP are indispensable for Pak3-augmented activation of
HTLV-1 LTR by Tax.
Tax and CRTC1 associate with Paks
Pak3 was previously shown to interact with Tax [18].
Since Pak1 shares 80% identical amino acid residues with
Pak3 [19], we investigated whether Pak1 might also form a
protein complex with Tax in cells. Using an anti-Flag
(α-Flag) antibody, we precipitated Flag-tagged Pak1 from
cultured HEK293T cells (Additional file 4: Figure S4A).
In cells expressing both Tax and Pak1, Tax was found in
the α-Flag precipitates (Additional file 4: Figure S4B,Figure 2 Pak3 augments Tax-induced HTLV-1 LTR activation in a kina
forms of Pak3. HeLa cells were transfected with expression plasmids for the
The harvested cells were untreated or treated with calf intestinal phosphat
blotting with anti-myc and anti-α-tubulin antibodies, respectively. (B) Activ
activation. Dual luciferase assays were carried out as in Figure 1.lane 3). However, the Tax-Pak1 complex was not
detected in control cells expressing Tax or Pak1 alone
(Additional file 4: Figure S4B, lanes 1 and 2). Likewise,
the association between Pak3 and Tax was also con-
firmed (Figure 5A and B). Moreover, the M5 mutant of
Pak3 containing the N-terminal regulatory domain
alone (Figure 3A) was sufficient for association with Tax
(Figure 5C and D). These results indicated that Pak1
and Pak3 can form a complex with Tax in cultured
mammalian cells.
Tax interacts with Pak1 (Additional file 4: Figure S4B)
and with CRTC1 individually [8]. In addition, Tax, Pak1
and CRTC1 can all be localized to the nucleus [8,39,40].
However, it was still unclear whether all three proteinsse-independent manner. (A) Expression of wild-type and mutant
indicated Pak3 proteins. Cells were harvested 48 hrs post transfection.
ase (CIP) at 37°C for 30 min. Proteins were analyzed by Western
ity profile of Pak3 wild-type and mutants on Tax-induced LTR
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gate this, we expressed all three proteins in HEK293T cells
and precipitated V5-tagged CRTC1 using an α-V5 antibody
(Additional file 4: Figure S4C). The α-V5 precipitates
contained both Pak1 and Tax (Additional file 4: Figure S4C,
lanes 6 and 9). This was consistent with the formation of a
protein complex that contains CRTC1, Pak1 and Tax. We
also noted the association of Pak1 with CRTC1 in the ab-
sence of Tax (Additional file 4: Figure S4C, lane 5). Similar
results compatible with the formation of CRTC1-Pak3
and CRTC1-Pak3-Tax protein complexes were also
obtained (Figure 5E, lanes 9, 10 and 15). Hence, Pak1 and
Pak3 associate with Tax and CRTC1.
Paks are recruited to HTLV-1 LTR
The association of Paks with Tax and CRTC1 plausibly in
the nucleus raised the possibility that Paks might also be
recruited to HTLV-1 LTR. To test this idea, we checked
for the binding of Tax and Paks to HTLV-1 LTR using
ChIP assay (Figure 6). We noted that overexpression of
Pak1 or Pak3 alone in HeLa cells constitutively carryingFigure 3 Mapping the Tax-augmenting domain in Pak3. (A) A diagram
expression in HeLa cells was detected by Western blotting with anti-myc a
mutants on Tax-induced LTR activation. Dual luciferase assays were carriedHTLV-1 LTR was not sufficient to induce the recruitment
of either kinase to the LTR (Figure 6,A and B, upper
panels, lanes 3). However, when Pak1/3 and Tax were
coexpressed, a more pronounced DNA band derived from
the three 21-bp TREs in the LTR was amplified from the
Pak1/3-DNA and Tax-DNA complexes (Figure 6,A and B,
upper and middle panels, lanes 4). Likewise, the M5 mu-
tant of Pak3 capable of interacting with and activating Tax
(Figure 3C and Figure 5D) was also recruited to the LTR
in the presence of Tax (Figure 6C, upper and middle
panels, lanes 4). Furthermore, expression of Tax alone in
HeLa cells resulted in the recruitment of endogenous
Pak1 and Pak3 to the LTR (Figure 6D, lanes 2 compared
to lanes 1). These results were compatible with the
model that Tax facilitates the recruitment of Paks to
HTLV-1 LTR.
Paks are required for optimal Tax activity
To shed light on the requirement of Paks for the activity
of Tax to interact with CRTCs and to be recruited to the
LTR, we performed loss-of-function assays with siPak1/3of Pak3 truncated mutants. (B) Expression of Pak3 mutants. Protein
nd anti-α-tubulin antibodies. (C) Activity profile of Pak3 truncated
out as in Figure 1.
Figure 4 Requirement of CREB, TORCs and p300/CBP for Pak3-augmented activation of HTLV-1 LTR by Tax. Escalating amounts of
A-CREB (A), CRTC1M1 (B), and E1A-12S (C) plasmids were transfected into HeLa cells. Dual luciferase assays were carried out as in Figure 1.
Numbers at the top of the error bars indicate fold activation. Expression of A-CREB, CRTC1M1 and E1A-12S was verified by Western blotting with
mouse anti-Flag, rabbit anti-Gal4 and rabbit anti-E1A antibodies (insets). n.s.: non-specific proteins reactive with anti-Gal4.
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Figure 5 Association of Pak3 with Tax and CRTC1 in cultured cells. (A and B) Pak3 interacts with Tax. HEK293T cells were co-transfected with
expression plasmids for Tax and Flag-Pak3. Pak3 was immunoprecipitated with anti-Flag. The precipitates were analyzed by Western Blotting
using anti-Flag (A) and anti-Tax (B) to detect Pak3 and Tax, respectively. (C and D) M5 mutant of Pak3 associates with Tax. (E) Pak3 interacts with
Tax and CRTC1. HEK293T cells were co-transfected with expression plasmids for Flag-Pak3, Tax and CRTC1-V5. CRTC1 was immunoprecipitated
with anti-V5. CRTC1, Pak3 and Tax in the precipitates were detected with anti-V5, anti-Flag and anti-Tax antibodies, respectively.
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dogenous Pak1, but neither CRTC1 nor Tax, was effi-
ciently suppressed by siPak1A (Figure 7A, right panels,
lanes 4 compared to lanes 3). We then pulled down
CRTC1-containing complex with a monoclonal anti-V5
antibody and Tax was detected in this complex
(Figure 7A, left panels). Notably, the relative amount of
CRTC1-bound Tax was significantly reduced in Pak1-
depleted cells (Figure 7A, left lower panel, lane 4 com-
pared to lane 3). Thus, Pak1 is indispensible for optimal
interaction of Tax with CRTC1.
We next assessed LTR recruitment of Tax in Pak1/3-
depleted cells. As anticipated, suppression of Pak1/3 ex-
pression in HeLa cells by siPak1/3 also compromised
their recruitment to the LTR (Figure 7B, middle panels).In addition, LTR recruitment of Tax was also suppressed
in siPak1/3-transfected cells (Figure 7B, upper panel,
lanes 3 and 4 compared to lane 2, and lane 7 compared
to lane 6). These results suggest that group 1 Paks are
also necessary for Tax recruitment to HTLV-1 LTR.
Paks are required for optimal HTLV-1 transcription
Above we have characterized the ability of group I Paks
to augment Tax-induced LTR activation. We have also
demonstrated the requirement of Paks for optimal activ-
ity of Tax to interact with CRTC1 and to be recruited to
the LTR. If Paks indeed function to facilitate Tax in
HTLV-1-infected cells, compromising Paks should exert
a suppressive effect on HTLV-1 proviral transcription.
With this in mind, we depleted Pak expression in HeLa
Figure 6 Recruitment of Paks to HTLV-1 LTR in the presence of Tax. (A to C) Recruitment of Pak1 (A), Pak3 (B) and Pak3-M5 (C) was
assessed by ChIP. HeLa cells carrying LTR-Luc were co-transfected with expression vectors for Tax and myc-Pak1/3 or myc-M5 as indicated. After
48 h, the transfected cells were subjected to cross-linking with 1% formaldehyde for 10 min at 37°C. Cells were washed and then lysed with lysis
buffer supplemented with protease inhibitor cocktail. The DNA-protein complex was sonicated, and the cell debris was removed by
centrifugation. Myc-tagged Pak1/3-Tax-LTR promoter complex was immunoprecipitated using anti-myc or anti-Tax antibody and the LTR
sequence was PCR-amplified. (D) Recruitment of endogenous Pak1 and Pak3. HeLa cells were co-transfected with Tax expression plasmid and
pLTR-Luc. ChIP was performed with the indicated antibodies and the LTR sequence was PCR-amplified from the precipitated DNA-protein
complex as above.
Figure 7 Compromising Paks prevents CRTC1-Tax association and Tax recruitment to LTR. (A) RNAi depletion of endogenous Pak1
impedes the association of Tax with CRTC1. HeLa cells were transfected with the indicated expression plasmids and an siRNA against Pak1
(siPak1A). Interaction of Tax with CRTC1 was analyzed as in Figure 5. n.s.: non-specific protein reactive with anti-Pak1. (B) RNAi depletion of Pak1
and Pak3 perturbs the recruitment of Tax to HTLV-1 LTR. HeLa cells were firstly transfected with siGFP, siPak1 and siPak3. siGFP served as a
negative control. After 24 h of siRNA transfection, cells were transfected with Tax expression plasmid and pLTR-Luc. Cells were harvested for ChIP
assay using the indicated antibodies after another 48 h.
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Figure 8 Compromising Paks suppresses HTLV-1 proviral gene transcription. (A) RNAi depletion of endogenous Pak1 and Pak3 decreases
the expression of HTLV-1 proviral mRNA transcripts. HeLa cells were transfected with siPak1 or siPak3 to knockdown endogenous Pak1 and Pak3,
respectively. After 24 h, cells were transfected with HTLV-1 molecular clone pX1MT. Cells were harvested 48 h after pX1MT transfection. Total RNA
was extracted by Trizol and cDNA was synthesized. Quantitative RT-PCR was performed to analyze the relative levels of proviral Tax, Gag, Env,
Pak1, Pak4 and β-globin transcripts. siGFP was used as a negative control. Relative expression levels were analyzed by normalizing to β-globin
and fold difference represent 2–ΔΔCT. (B) RNAi depletion of Pak1 and Pak3 decreases the expression of Tax transcript in HTLV-1-transformed T
cells. MT4 cells were transfected with siGFP, siPak1 and siPak3. siGFP was used as a negative control. After 72 h of siRNA transfection, total RNA
was extracted and quantitative RT-PCR was performed. (C) Proliferation of MT4 cells was unaffected by siPak1/3 as measured by the MTT assay.
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pX1MT, an infectious clone of HTLV-1 that can drive
the expression of viral proteins and the production of in-
fectious virions [41]. The expression of viral and cellulartranscripts was then monitored by real-time RT-PCR.
siPak1 and siPak3 were effective in dampening the ex-
pression of Pak1, but not Pak4 (Figure 8A, bars 6, 11, 16
and 21 compared to bar 1, and bars 10, 15, 20 and 25
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substantially inhibit the expression of Tax, Gag and Env
transcripts (Figure 8A, bars 7–9, 12–14, 17–19 and 22–
24 compared to bars 2–4). Thus, Paks are required for
optimal transcriptional activation of HTLV-1 by Tax.
On the other hand, we also measured the expression
of Pak1 and Tax transcripts in HTLV-1-transformed
and Tax-expressing MT4 cells transfected with siPaks
(Figure 8B). Again, silencing of Pak1 or Pak3 correlated
with down-regulation of Tax expression (Figure 8B,
bars 3–8), but did not apparently affect cell proliferation
(Figure 8C). Taken together, these results provided fur-
ther support to the notion that group I Paks are facilita-
tors of Tax-activated HTLV-1 transcription in both
acutely and chronically infected cells.
Discussion
In this study, we provided the first evidence for a facilita-
tor function of group I Paks in Tax-induced activation of
HTLV-1 LTR. This kinase-independent function of Pak1,
Pak2 and Pak3 was characterized in the context of Tax
and HTLV-1 LTR (Figures 1 and 2). CREB, CRTCs, p300/
CBP and the N-terminal regulatory domain of Paks are in-
dispensable for this function (Figures 3, 4, 5 and 6). Paks as-
sociate with Tax and CRTCs and are recruited to HTLV-1
LTR by Tax (Figures 5, 6 and Additional file 4: Figure S4).
Compromising Paks by RNAi resulted in a suppression
of the interaction of Tax with CRTC1 and the recruit-
ment of Tax to the LTR (Figure 7), plausibly leading to
an inhibition of HTLV-1 transcription in cells infected
with an HTLV-1 clone and in HTLV-1-transformed
T cells (Figures 1, 8, Additional file 1: Figures S1 and
Additional file 2: Figures S2). Collectively, our findings
reveal new mechanistic details of Tax-induced tran-
scriptional activation of HTLV-1 LTR, in which Tax
interacts with and recruits group I Paks to the TRE
enhancers to facilitate transcription.
Group I Paks are Cdc42/Rac-regulated kinases that
regulate transcription, cell cycle, cell motility and other as-
pects of cell physiology [19,20]. Some functions of Paks do
not require their kinase activity [24-27]. For example,
Pak1 induces lamellipodia formation and membrane ruf-
fling through its N-terminal regulatory domain in a
kinase-independent fashion [24,25]. Inhibition of cell cycle
progression by the CRIB domain of Pak1 is also independ-
ent of its kinase activity [26]. In addition, Pak1 serves a
kinase-independent scaffolding role in Akt signaling [27].
However, it is still surprising that group I Paks augment
Tax transcriptional activity on HTLV-1 LTR in a kinase-
independent manner. Exactly how these Paks facilitate
Tax in LTR activation remains to be elucidated. The
diminution of CRTC1- and LTR-bound Tax in Pak1/3-
compromised cells (Figure 7) was in support of an adaptor
function of group I Paks in Tax-induced activation of theLTR. On the other hand, Pak1 was previously shown to
stimulate transcription when tethered to the promoter
through Gal4 DNA-binding domain (Gal4BD) [37]. One
alternative mechanism by which Pak1 modulates tran-
scription is through inactivation of transcriptional core-
pressor CtBP [42], which inhibits the function of CBP
[43]. Pak1 also interacts with and phosphorylates histone
H3 [44]. We found that the M5 mutant of Pak3 containing
the N-terminal regulatory domain alone could sufficiently
interact with Tax, promote Tax recruitment to the LTR, and
augment Tax-induced LTR activation (Figures 3, 5 and 6).
Although neither CRIB nor kinase activity was required for
the augmentation of Tax activity (Figures 2 and 3),
we cannot completely rule out the involvement of the
kinase domain since the Tax-augmenting activity of M1
lacking the kinase domain was weakened compared to the
wild type (Figure 3). Our experiments suggested that the
augmentation of Tax activity by group I Paks could not by-
pass CREB, CRTCs or p300/CBP (Figure 4). However, our
analysis could not distinguish the effect of the dominant
inhibitors of CREB, CRTC1 and p300/CBP on Tax or on
Paks. Particularly, the incomplete inhibitory effect of
CRTC1M1 (Figure 4B) suggested that compromising
CRTC1 alone is insufficient to abrogate the activity of Tax
and Pak3. It will be of interest to determine whether
CRTC2 and CRTC3 could account for the remaining ac-
tivity of Tax and Pak3 in the presence of CRTC1M1.
Exactly how Paks affect the activity of CREB, CRTCs and
p300/CBP remains to be elucidated. In this regard, we
showed that depletion of Pak1 suppressed the recruitment
of Tax to the LTR (Figure 7B). Because Tax is required
for the recruitment and activation of CREB, CRTCs and
p300/CBP [5-9], the activity of these transcriptional regu-
lators should also be compromised in the absence of Paks.
At least three additional lines of experiments are required
to derive mechanistic insight on the transcriptional regula-
tory function of group I Paks. First, the dispensability of
the kinase domain for the augmentation of Tax activity
should be determined. Second, the M5 mutant recruited
to the promoter through Gal4BD should be assessed for
transcriptional activity. Finally, possible involvement of
CtBP and histone H3 phosphorylation in Pak-augmented
activation of HTLV-1 LTR by Tax should be investigated.
Emerging evidence implicates group I Paks in supporting
the replication of various human viruses [23]. Thus, associ-
ation and activation of Pak2 by viral Nef protein were
thought to play a role in HIV-1 replication [45]. In addition,
an RNAi screen identified Pak1 and Pak3 to be important
host factors that support HIV-1 infection in HeLa cells and
T lymphocytes [46]. On the other hand, hepatitis B virus
oncoprotein HBx was recently shown to activate Pak1 to
promote cell survival [47]. Our findings that group I Paks
facilitate HTLV-1 transcription are generally consistent with
the notion that these Paks play an important role in the life
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inhibitors of Paks are thought to be attractive therapeutic
agents for different types of cancer and viruses [48]. Be-
cause the facilitator function of Paks on Tax-induced LTR
activation is kinase-independent, kinase inhibitors of Paks
might not be useful in anti-HTLV-1 therapy. However, pep-
tide mimetics that can inhibit the interaction between Paks
and Tax would still hold the promise for the design and de-
velopment of new molecularly targeted anti-HTLV-1 and
anti-ATL therapeutics.
Group I Paks are a critical regulatory point in cell signal-
ing on which diverse upstream signals converge [18,19]. It
remains to be understood how these signals might affect
the interaction between Tax and Paks. Tax appears to be
able to promote the recruitment of Paks to HTLV-I LTR
(Figure 6). The mechanisms of this recruitment and
the cellular factors that regulate this process warrant
further investigations. Paks are frequently upregulated in
cancer cells and virus-infected cells [19,23]. In line
with this, Pak1 and Pak3 were found to be expressed in
HTLV-1-transformed leukemic cells and compromising
their expression led to inhibition of HTLV-1 transcription
(Figures 1, 8, Additional file 1: Figure S1 and Additional
file 2: Figure S2). To understand whether group I Paks
might indeed be induced by HTLV-1 infection, expression
profiles of Pak mRNA and protein in HTLV-1-infected in-
dividuals and ATL patients should be determined system-
atically. Pak1, Pak2 and Pak3 are strikingly homologous
and serve redundant and non-redundant functions in cells
[18,19]. We found that all three were equally active in fa-
cilitating Tax-induced LTR activation (Figure 1). Compar-
ing their relative abundance in HTLV-1-infected T cells in
patients will shed light on whether they are differentially
expressed and which ones might be more important in
HTLV-1 transcription.
The activation of CREB signaling by Tax not only me-
diates LTR activation, but is also required for full-blown
oncogenic transformation [15,49]. In addition to the
LTR, Tax also activates a wide array of cellular genes
through CREB to effect cell proliferation and survival
[47,48]. We noted in our study that Pak1 and Pak3 asso-
ciated with CRTC1 even in the absence of Tax (Figures 5
and Additional file 4: Figure S4), raising the possibility
that group I Paks might serve a general facilitator func-
tion in cellular CREB-dependent transcription. That is
to say, group I Paks could act as cofactors in CREB-
induced cellular transformation. In HTLV-1-infected
cells, Tax might further enhance the activity of Paks to
facilitate CREB-dependent transcription by recruiting
them to CRE-containing promoters. In this regard, full
characterization of the role of group I Paks in the activa-
tion of cellular CREB-regulated genes both in the ab-
sence and in the presence of Tax will enable us to have a
complete picture of how Tax, group I Paks and CREBcooperate to mediate transcriptional activation and
oncogenic transformation.
Conclusion
We demonstrate that group I Paks interact with HTLV-1
Tax and are recruited to the LTR to serve a kinase-
independent facilitator function in Tax-induced activation
of LTR transcription.
Methods
Cell culture and transfection
HeLa and HEK293T cells were cultured in Dulbecco's
modified Eagle's medium supplemented with 10% fetal bo-
vine serum. Jurkat and HTLV-1-transformed T cells MT2
and MT4 were maintained in RPMI medium supplemented
with 10% fetal bovine serum. HeLa and HEK293T cells
were transfected using GeneJuice transfection reagent
(Novagen). Jurkat, MT2 and MT4 cells were transfected
using Lipofectamine 2000 (Invitrogen).
RNA interference
RNA knockdown experiments were carried out as de-
scribed [51,52]. HeLa, Jurkat, MT2 and MT4 cells were
transfected with 100 nM siRNA using Lipofectamine
2000 (Invitrogen). siRNA sequences are as follows:
siPak1A: 5′-GCUCUGUCAA GCUAACUGAdT dT-3′
siPak1B: 5′-GCUCUGGAGU UCUUGCAUUdT dT-3′
siPak3A: 5′-CAACCCAAGA AGGAAUUAAdT dT-3′
siPak3B: 5′-CCAGAUCACU CCUGAGCAAdT dT-3′
siTax-A: 5′-GGCCUCAUAC AGUACUCUUdT dT-3′
siTax-B: 5′-GGCAGAUGAC AAUGACCAUdT dT-3′
siGFP: 5′-GAAGCAGCAC GACUUCUUCdT dT-3′
Plasmids
Reporter plasmid pLTR-Luc and expression plasmids for
Tax, A-CREB, CRTC1, CRTC1M1 and Pak1 were described
elsewhere [4,8,21,36,37]. pLTR-Luc contains the full LTR of
HTLV-1. Reporter plasmid pTRE-Luc was constructed by
inserting into pGL3-basic (Promega) three copies of TREs
amplified from HTLV-1 LTR using primers 5′-CCCAAGC
TTG GTCAGGGCCC AGACTAAGGC TC-3′ and 5′-CC
CAAGCTTT GGATGGCGGC CTCAGGTAAG G-3′. Re-
porter plasmid pHIAP-Luc was a gift from R. Grassmann
[29]. Expression plasmid for E1A-12S was provided by J.
Lundblad [38]. HTLV-1 molecular clone pX1MT was pro-
vided by D. Derse [41]. Pak2 expression construct was pro-
vided by W. Hahn [53] and Pak2 was subcloned using
primers 5′-GGGGTACCAT CATGTCTGAT AACGGAG
AAC TGGAAG-3′ and 5′-ATAAGAATGC GGCCGCT
TAA CGGTTACTCT TCATTGCTTC TTT-3′. Pak3 was
derived from I.M.A.G.E. cDNA clone 4798769 and was
amplified using primers 5′-GCGGATCCAG ATGTCTGA
CG GTCTGGATA ATG-3′ and 5′-CCGCTCGAGT TA
GCGGCTGC TGTTCTTAAT TGCTTCC-3′. R67C,
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constructed by PCR method using the following sets of
sense (s) and antisense (as) primers (the mutated nucleo-
tides are underlined):
R67C-s: 5′-CCAATAAGAA GAAAGAGAAA GAGT
GCCCAG AGATCTCTCT TCC-3′
R67C-as: 5′-GGAAGAGAGA TCTCTGGGCA CTC
TTTCTCT TTCTTCTTAT TGG-3′
K297L-s: 5′-GAGGTGGCCA TACTGCAGAT GAA
CCTTCAA CAGC-3′
K297L-as: 5′-GCTGTTGAAG GTTCATCTGC AGT
ATGGCCACC TC-3′
A365E-s: 5′-CCTGTATGGA TGAAGGACAG ATAG
AAGCTG TCTG-3′
A365E-as: 5′-CAGACAGCTT CTATCTGTCC TTCA
TCCATA CAGG-3′
R419X-s: 5′-CTGAGCAAAG TAAATGAAGC ACTA
TGGTGG GAAC-3′
R419X-as: 5′-GTTCCCACCA TAGTGCTTCA TTTA
CTTTGC TCAG-3′
T421E-s: 5′-CTGAGCAAAG TAAACGAAGC GAGA
TGGTGG GAAC-3′
T421E-as: 5′-GTTCCCACCA TCTCGCTTCG TTTA
CTTTGC TCAG-3′
Truncated mutant M4 of Pak3 was made by PCR using
primers 5′-GCGGATCCAG ATGCGCCCAG AGATCT
CTCT TCCTTCA-3′ and 5′-CCGCTCGAGT TACTTC
TTCT GTTCCAATTT TGTTATGTTG G-3′. Truncated
mutants M1, M2, M3 and M5 of Pak3 were generated by
PCR using the common sense primer 5′-GCGGATCCAG
ATGTCTGACG GTCTGGATAA TG-3′ and the follow-
ing anti-sense primers:
M1-as: 5′-CCGCTCGAGT TATGCTGGTG AAG
CAATGGA TTCAACCAC-3′
M2-as: 5′-CCGCTCGAGT TAATGGGCTG CTATG
TATCC ATGTGCACT-3′
M3-as: 5′-CCGCTCGAGT TATGGGTTCT TCTTCT
GTTC CAATTTTGTT AT-3′
M5-as: 5′-CCGCTCGAGT TAGATCTCTG GGCGC
TCTTT CT-3′Luciferase reporter assays
Dual luciferase assay was carried out as previously de-
scribed [8,37]. Transfection efficiencies were normalized
to pSVRL control plasmid expressing Renilla luciferase
(Promega).
RT-PCR analysis
RNA was extracted using Trizol reagent (Invitrogen).
RNA (2 μg) was digested with DNase I (Ambion) at 37°C
for 30 min. cDNA synthesis was performed using oligo
(dT). Semi-quantitative RT-PCR was performed as previ-






XII-s: 5′-CGGATACCCA GTCTACGTGT TTG-3′
XII-as: 5′-GGGAGTCGAG GGATAAGGAA CT-3′
Pak1-s: 5′-TGAGAGCCTT GTACCTCATT GCCA-3′
Pak1-as: 5′-TCCTTAGCTG CAGCAATCAG TGGA-3′
Pak3-s: 5′-ACAACCGGGATTCTTCAGCA CTCA-3′
Pak3-as: 5′- AGTAATCGTG CCCATTGCTC TGGA-3′
globin-s: 5′-AGCGTACTCC AAAGATTCAG GTT-3′
globin-as: 5′-TACATGTCTC GATCCCACTT AACTA
T-3′
Real-time RT-PCR was performed as previously de-
scribed [37,50]. Relative expression levels were quantified
by normalizing to the corresponding β-globin values using
the comparative threshold cycle method where:
Fold difference = 2–(ΔCT of gene of interest - ΔCT of β-globin) =
2–ΔΔCT












Co-immunoprecipitation was carried out as described
[52,54]. HEK293T cells were lysed with lysis buffer (20 mM
Tris–HCl, pH 7.5, 100 mM NaCl, 0.1% NP-40, and 0.5 mM
EDTA) supplemented with protease inhibitors (Roche). Cell
debris was removed by centrifugation at 14,000 rpm at 4°C.
Cell lysate was incubated with primary antibodies at 4°C
overnight. The immunocomplex was incubated with 30 μl
protein A-agarose (Invitrogen), washed three times with
lysis buffer, and then resuspended with SDS-PAGE loading
buffer (60 mM Tris-Cl, 2% SDS, 6% glycerol, 1% β-
mercaptoethanol, and 0.002% bromophenol blue).
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed as
previously described [37,55]. HeLa cells were cross-linked
by 1% formaldehyde for 10 min at room temperature. The
DNA–protein complex was immunoprecipitated, and
the genomic DNA was purified by phenol-chloroform ex-
traction. Promoter sequence spanning the three 21-bp
TREs in HTLV-1 LTR was PCR-amplified using primers
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Cell proliferation assay
Cell proliferation assay was performed using the (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium (MTT) method
[56]. MT4 cells (5 × 104) were treated with 5 mg/ml MTT
solution (10 μl) and OD550 was measured with a
microplate reader (Spectra Max 340, Molecular Devices).
Cell proliferation was presented as a percentage of the
control.
Additional files
Additional file 1: Figure S1. Knockdown of Paks alleviates LTR activity in
T cells. (A) Silencing of Paks represses LTR activation by Tax in Jurkat cells.
Jurkat cells were transfected with siRNA (siPak1 or siPak3) to deplete
endogenous Pak1 or Pak3. After 30 h, cells were co-transfected with
expression vector for Tax and pLTR-Luc reporter plasmid. Dual luciferase
activity was assayed as in Figure 1.*: the difference between groups 5 and 4
is statistically significant (p = 0.0013 by Student's t test). #: p = 0.0006.
(B) Silencing of Pak1 alleviates LTR activity in MT4 cells. Cells were
transfected with the indicated plasmids, and harvested for dual luciferase
assay after 48 h. @: the difference between groups 4 and 3 is statistically
significant (p = 0.013 by Student's t test).
Additional file 2: Figure S2. Repression of HTLV-1 proviral gene
transcription by depleting Pak1/3. HeLa (A) and MT4 (B) cells were
co-transfected as in Figure 7. Semi-quantitative RT-PCR was performed.
Indicated at the bottom of the panels are relative amounts of Pak1 or Pak3
transcript normalized to β-globin (β-glb) mRNA (*/@ and #/@) as
determined by densitometric analysis of band intensity.
Additional file 3: Figure S3. Pak3 augments LTR activation by Tax
mutants. HeLa cells were transfected with the indicated plasmids and
analyzed as in Figure 1.
Additional file 4: Figure S4. Pak1 interacts with Tax and CRTC1 in
HEK293T cells. Cells were co-transfected with expression vectors for Pak1,
CRTC1 and Tax as indicated. Co-immunoprecipitation and Western
blotting were performed as in Figure 5.
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